Australia cracks down on unproven stem cell therapies
As in the US, unproven stem cell therapies have been marketed in Australia.Therapeutic Goods Administration (TGA, similar to US FDA) of the Australian Government tightened regulations around advertising autologous (ser) human cell and tissue products.
As of July 1, 2018, these products cannot be marketed to consumers, and adverse events must be reported to the TGA.
Interesado en saber si los programas clínicos actuales, desarrollos de investigacion, o enfoques terapéuticos emergentes pueden ser relevantes para su situación?
Información educativa y de investigación únicamente.. Las decisiones médicas individuales deben tomarse en consulta con profesionales sanitarios cualificados..
